FENC · Forms 3, 4, 5
Insider trades at FENNEC PHARMACEUTICALS INC.
4 insiders sold $1.4M of FENNEC PHARMACEUTICALS INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for FENNEC PHARMACEUTICALS INC. (FENC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Pierre Sargis Sayad | Chief Medical Officer | Award | 3,846 | $5.53 | $21K | Form 4 | |
| Jeffrey S. Hackman | Chief Executive Officer | Award | 2,224 | $5.53 | $12K | Form 4 | |
| Terry L Evans | Chief Commercial Officer | Award | 2,326 | $5.53 | $13K | Form 4 | |
| Christiana Marie Cioffi | Chief Strategy Officer | Award | 3,946 | $5.53 | $22K | Form 4 | |
| Robert Andrade | CHIEF FINANCIAL OFFICER | Award | 3,846 | $5.53 | $21K | Form 4 | |
| Pierre Sargis Sayad | Chief Medical Officer | Award | 168 | Form 4 | |||
| Terry L Evans | Chief Commercial Officer | Award | 168 | Form 4 | |||
| Jeffrey S. Hackman | Chief Executive Officer | Award | 1,159 | Form 4 | |||
| Christiana Marie Cioffi | Chief Strategy Officer | Award | 156 | Form 4 | |||
| Robert Andrade | CHIEF FINANCIAL OFFICER | Award | 1,703 | Form 4 | |||
| Marco Maria Brughera | Director | Option exercise | 15,545 | $2.11 | $33K | Form 4 | |
| Marco Maria Brughera | Director | Sell (10b5-1 plan) | 15,545 | $10.29 | $160K | Form 4 | |
| Rosty Raykov | Sell (10b5-1 plan) | 10,000 | $12.11 | $121K | Form 4 | ||
| Rosty Raykov | Award | 2,778 | Form 4 | ||||
| Pierre Sargis Sayad | Chief Medical Officer | Award | 168 | Form 4 | |||
| Pierre Sargis Sayad | Chief Medical Officer | Sell | 12,000 | $12.18 | $146K | Form 4 | |
| Terry L Evans | Chief Commercial Officer | Award | 168 | Form 4 | |||
| Christiana Marie Cioffi | Chief Strategy Officer | Award | 156 | Form 4 | |||
| Jeffrey S. Hackman | Chief Executive Officer | Award | 1,159 | Form 4 | |||
| Robert Andrade | CHIEF FINANCIAL OFFICER | Award | 1,703 | Form 4 | |||
| Robert Andrade | CHIEF FINANCIAL OFFICER | Option exercise | 21,928 | $5.10 | $112K | Form 4 | |
| Robert Andrade | CHIEF FINANCIAL OFFICER | Sell (10b5-1 plan) | 75,000 | $11.78 | $884K | Form 4 | |
| Rosty Raykov | Sell (10b5-1 plan) | 10,000 | $9.58 | $96K | Form 4 | ||
| Pierre Sargis Sayad | Chief Medical Officer | Award | 168 | Form 4 | |||
| Terry L Evans | Chief Commercial Officer | Award | 168 | Form 4 | |||
| Christiana Marie Cioffi | Chief Strategy Officer | Award | 156 | Form 4 | |||
| Jeffrey S. Hackman | Chief Executive Officer | Award | 1,159 | Form 4 | |||
| Rosty Raykov | Award | 2,778 | Form 4 | ||||
| Robert Andrade | CHIEF FINANCIAL OFFICER | Award | 1,703 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.